Mental Disorders

At Boehringer Ingelheim Mental Health, we are redefining mental health to enable people to thrive. We link behavior to the underlying neurobiology to develop targeted therapies that can ease the burden of these conditions, not just the symptoms. By combining traditional treatment approaches with new and innovative approaches and technologies, we will enable those with mental health conditions such as Schizophrenia, Borderline Personality Disorder or Depression to create more meaningful connections to their lives, loved ones and society.

Boehringer Ingelheim has a rich pipeline in all phases of development.

NP-GB-103338    October 2022